Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development of niche drug. The company’s overall business strategy comprises of utilizing our Taiwan headquarter as our global R&D center and establishing our presence in the world’s two largest pharmaceutical markets (the US and China) through US subsidiaries and Hangzhou Handa Pharmaceutical Technology Co., Ltd., respectively.
Handa Pharma integrates its own pharmaceutical development platform with patent analysis, medicine and pharmaceuticals regulatory, and market planning to focus on the development of high barrier/patentable niche products, including：
- 505(b)(2) New drug development
- High barrier/patentable generics development